日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Liquid biomarkers in melanoma: detection and discovery

黑色素瘤液体生物标志物:检测与发现

Lim, Su Yin; Lee, Jenny H; Diefenbach, Russell J; Kefford, Richard F; Rizos, Helen

Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti-Programmed Cell Death 1 Antibodies

循环肿瘤DNA与接受抗程序性细胞死亡蛋白1抗体治疗的转移性黑色素瘤患者的假性进展之间的关联

Lee, Jenny H; Long, Georgina V; Menzies, Alexander M; Lo, Serigne; Guminski, Alexander; Whitbourne, Kataraina; Peranec, Michelle; Scolyer, Richard; Kefford, Richard F; Rizos, Helen; Carlino, Matteo S

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)

III期随机研究:高剂量干扰素α-2b治疗T2bNO、T3a-bNO、T4a-bNO和T1-4N1a-2a(显微镜下)黑色素瘤4周:东部肿瘤协作组-美国放射学会影像网络癌症研究组的一项试验(E1697)

Agarwala, Sanjiv S; Lee, Sandra J; Yip, Waiki; Rao, Uma N; Tarhini, Ahmad A; Cohen, Gary I; Reintgen, Douglas S; Evans, Terry L; Brell, Joanna M; Albertini, Mark R; Atkins, Michael B; Dakhil, Shaker R; Conry, Robert M; Sosman, Jeffrey A; Flaherty, Lawrence E; Sondak, Vernon K; Carson, William E; Smylie, Michael G; Pappo, Alberto S; Kefford, Richard F; Kirkwood, John M

Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients

评估两种高通量蛋白质组学技术在接受免疫疗法治疗的黑色素瘤患者血浆生物标志物发现中的应用

Lim, Su Yin; Lee, Jenny H; Welsh, Sarah J; Ahn, Seong Beom; Breen, Edmond; Khan, Alamgir; Carlino, Matteo S; Menzies, Alexander M; Kefford, Richard F; Scolyer, Richard A; Long, Georgina V; Rizos, Helen

Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms

获得性BRAF抑制剂耐药:耐药机制的谱系和频率、临床表现和表型关联的多中心荟萃分析

Johnson, Douglas B; Menzies, Alexander M; Zimmer, Lisa; Eroglu, Zeynep; Ye, Fei; Zhao, Shilin; Rizos, Helen; Sucker, Antje; Scolyer, Richard A; Gutzmer, Ralf; Gogas, Helen; Kefford, Richard F; Thompson, John F; Becker, Jürgen C; Berking, Carola; Egberts, Friederike; Loquai, Carmen; Goldinger, Simone M; Pupo, Gulietta M; Hugo, Willy; Kong, Xiangju; Garraway, Levi A; Sosman, Jeffrey A; Ribas, Antoni; Lo, Roger S; Long, Georgina V; Schadendorf, Dirk

Thank you to all our manuscript reviewers in 2014

感谢所有在2014年审稿的稿件审稿人。

Harland, Mark; Cust, Anne E; Badenas, Celia; Chang, Yu-Mei; Holland, Elizabeth A; Aguilera, Paula; Aitken, Joanne F; Armstrong, Bruce K; Barrett, Jennifer H; Carrera, Cristina; Chan, May; Gascoyne, Joanne; Giles, Graham G; Agha-Hamilton, Chantelle; Hopper, John L; Jenkins, Mark A; Kanetsky, Peter A; Kefford, Richard F; Kolm, Isabel; Lowery, Johanna; Malvehy, Josep; Ogbah, Zighereda; Puig-Butille, Joan-Anton; Orihuela-Segalés, Jordi; Randerson-Moor, Juliette A; Schmid, Helen; Taylor, Claire F; Whitaker, Linda; Bishop, D Timothy; Mann, Graham J; Newton-Bishop, Julia A; Puig, Susana; Lubinski, Jan; Scott, Rodney J; Sijmons, Rolf; Bayliss, Katie

Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor

对于单药BRAF抑制剂治疗后病情进展的BRAFV600突变型黑色素瘤患者,联合使用BRAF抑制剂(达拉非尼)和MEK抑制剂(曲美替尼)治疗。

Johnson, Douglas B; Flaherty, Keith T; Weber, Jeffrey S; Infante, Jeffrey R; Kim, Kevin B; Kefford, Richard F; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan; Sharfman, William H; McWilliams, Robert R; Sznol, Mario; Lawrence, Donald P; Gibney, Geoffrey T; Burris, Howard A 3rd; Falchook, Gerald S; Algazi, Alain; Lewis, Karl; Long, Georgina V; Patel, Kiran; Ibrahim, Nageatte; Sun, Peng; Little, Shonda; Cunningham, Elizabeth; Sosman, Jeffrey A; Daud, Adil; Gonzalez, Rene

Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors

评估基质HGF免疫反应性作为黑色素瘤对RAF抑制剂反应的生物标志物

Lezcano, Cecilia; Lee, Chung-Wei; Larson, Allison R; Menzies, Alexander M; Kefford, Richard F; Thompson, John F; Mihm, Martin C Jr; Ogino, Shuji; Long, Georgina V; Scolyer, Richard A; Murphy, George F

Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.

致癌的 B-RAF(V600E) 信号诱导 T-Box3 转录抑制因子抑制 E-钙黏蛋白并增强黑色素瘤细胞侵袭

Boyd Suzanah C, Mijatov Branka, Pupo Gulietta M, Tran Sieu L, Gowrishankar Kavitha, Shaw Heather M, Goding Colin R, Scolyer Richard A, Mann Graham J, Kefford Richard F, Rizos Helen, Becker Therese M

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

BRAF V600突变黑色素瘤的BRAF和MEK联合抑制

Flaherty, Keith T; Infante, Jeffery R; Daud, Adil; Gonzalez, Rene; Kefford, Richard F; Sosman, Jeffrey; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan; Ibrahim, Nageatte; Kudchadkar, Ragini; Burris, Howard A 3rd; Falchook, Gerald; Algazi, Alain; Lewis, Karl; Long, Georgina V; Puzanov, Igor; Lebowitz, Peter; Singh, Ajay; Little, Shonda; Sun, Peng; Allred, Alicia; Ouellet, Daniele; Kim, Kevin B; Patel, Kiran; Weber, Jeffrey